Latest News
The Yale Pediatrics Research Forum is taking place April 25, 2013 in the Anlyan Center, 5:30 PM - 8:15 PM.
- March 19, 2013
Researchers at Yale School of Medicine have made major discoveries that could lead to new treatments for lung disorders in premature babies. In a mouse study, the team located key molecules that switch on stress pathways in preterm lung disorders, and also found that when parts of these pathways were blocked with a pain drug, lung damage was prevented or reversed.
- November 19, 2006
Genetics play a major role in predisposing infants to retinopathy of prematurity (ROP), a disease prevalent in premature infants that disrupts normal blood vessel development of the retina and can lead to blindness, researchers at Yale School of Medicine report in the November issue of Pediatrics.
- November 04, 2006
Acute lung injury caused by cell death, high and potentially toxic concentrations of oxygen (hyperoxia), and the resulting excess fluid in the lungs (pulmonary edema), may be controlled by modulating levels of the angiopoietin2 (Ang2) protein, researchers at Yale School of Medicine report in the November 5 online issue of Nature Medicine.
- August 01, 2006
Genetics may be a risk factor in premature infants who develop problems in their lungs as a result of not reaching normal gestational age, according to a study at Yale School of Medicine.